Related Experiment Videos
[Excessive growth and growth hormone deficiency after treatment for craniopharyngioma]
J P López Siguero1, E García García, M J Martínez-Aedo
1Departamento de Pediatría, Hospital Materno-Infantil Carlos Haya, Málaga.
Insights
Children with craniopharyngioma may experience normal growth despite hormone deficiency after tumor removal. Growth hormone therapy can effectively boost growth rates in these cases.
Area of Science:
- Pediatric Endocrinology
- Neuro-oncology
- Growth Hormone Research
Background:
- Craniopharyngioma is a brain tumor often affecting the pituitary gland.
- Tumor removal can lead to panhypopituitarism, including growth hormone deficiency.
- Altered growth patterns are observed in some children post-surgery.
Observation:
- A 4-year-old girl with a suprasellar craniopharyngioma underwent tumor removal.
- Post-surgery, she developed panhypopituitarism.
- Initial rapid growth (8.4-10.6 cm/year) was followed by a decline to 1.2 cm/year.
Findings:
- Despite documented growth hormone deficiency, the patient exhibited significant initial growth.
- Growth hormone administration was initiated.
- Therapy successfully increased her growth rate to 9.3 cm/year.
Implications:
- This case highlights the complex interplay of factors influencing growth after craniopharyngioma treatment.
- It suggests potential alternative growth pathways or compensatory mechanisms in some children.
- Growth hormone therapy remains a crucial intervention for managing growth deficits in pediatric pituitary disorders.
Abstract:
Some children grow normally or excessively after extirpation of a craniopharyngioma, despite growth hormone deficiency. We report a 4-year-old girl with suprasellar craniopharyngioma. Removal of the tumor resulted in panhypopituitarism. For the next 5 years growth continued at a rate of 8.4-10.6 cm/year and then decreased progressively to 1.2 cm/year. Administration of growth hormone increased growth rate to 9.3 cm/year.